Fewer Asians, Blacks, Hispanics eligible for drugs that may delay Alzheimer's progression
The development of anti-amyloid monoclonal antibodies that may slow the progression of Alzheimer's disease by breaking down amyloid plaques, a hallmark of the disease, has brought fresh hope to aging populations and the doctors ...
Oct 3, 2022
0
9